Oya Köker

Methotrexate in Still’s Disease: An Updated Perspective on Efficacy and Safety

The EULAR/PreS and American College of Rheumatology (ACR) guidelines for Still's disease (SD) were recently published with new therapeutic management strategies to achieve therapeutic targets within a specified timeframe. The early use of interleukin (IL)-1 or IL-6 inhibitors ass...

Performance of Large Language Models in Answering Juvenile Systemic Lupus Erythematosus Questions: A Blinded Expert-based Comparative Study

Background: Large language models are increasingly used to obtain medical information, but their performance in juvenile systemic lupus erythematosus remains insufficiently characterized. Objective: To compare expert-rated response quality and clinical relevance across 4 artifici...